Preventive Cardiovascular Nurses Association

PCNA Login



Forgot Password?

Safe Management of Oral Anticoagulation: The Importance of the Patient as Partner

CONTINUING EDUCATION
RN, NP: 1 CE Credit (includes 1 contact hour pharmacology)
Release Date: August 2009

COURSE OVERVIEW:
This learning activity provides an overview of antithrombotic therapy and reviews the indications and mechanism of action of warfarin. The term "narrow therapeutic range" is defined and it becomes the context in which the complexities of managing warfarin therapy are presented. The June 2008 Eighth American College of Chest Physicians (ACCP) Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines are reviewed in detail, as is the Joint Commission 2008 National Patient Safety Goal 3E, "Reduce the likelihood of patient harm associated with the use of anticoagulation therapy." The importance of patient education is highlighted, and various operational models of care for patients on chronic oral anticoagulation are described.

EDUCATIONAL OBJECTIVES:
Upon completion of this program, participants will be able to:
  1. List three factors that increase bleeding risk in a patient taking warfarin
  2. Identify the level of stroke risk in a patient with a subtherapeutic INR
  3. Identify the Joint Commission's expectations for patient safety for patients taking warfarin
  4. List three options for follow-up INR measurement for patients taking warfarin
  5. Summarize the evidence regarding the safety of patient self-testing of INR

PRESENTER:
Suzanne Hughes, MSN, RN
Director, Health Education and Nursing Research
Robinson Memorial Hospital
Ravenna, OH
Biography
CE Course Outline

Step 1: Print slides/handouts (pdf)
Step 2: View Presentation (flash video)
Step 3: Quick Evaluation
Step 4: Print CE Certificate


Share |

Tell A Friend...
about this continuing education opportunity! Simply enter the email address of up to 3 colleagues, friends or family members and we will email them information about this program.

Email Addresses:

My Name:
My Email:

PRESENTER DISCLOSURES:
The presenter has no commercial relationships to disclose.

AUDIENCE:
Nurses, nurse practitioners, and other healthcare professionals interested in the prevention and management of cardiovascular disease.

COST:
This online educational activity is offered free of charge.

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the program materials, complete the online evaluation at the end of the activity, and print your CE certificate.

SPONSOR/ACCREDITOR:
This activity is sponsored by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Academy of Nurse Practitioners (AANP) as an approved provider of nurse practitioner continuing education, provider number 030602. This program is accredited for 1 contact hour which includes 1 hour of pharmacology. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

GRANTOR:
This activity is presented by PCNA through an educational grant from Inverness Medical.